Race modifies the association between breast carcinoma pathologic prognostic indicators and the positive status for HER-2/neu (Q81318609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Race modifies the association between breast carcinoma pathologic prognostic indicators and the positive status for HER-2/neu (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Azadeh T Stark

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sarah Claud

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Alissa Kapke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Mei Lu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Michael Linden

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jennifer Griggs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

2189-2196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Prognosis among African-American women and white women with lymph node negative breast carcinoma: findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Differences in breast cancer prognosis among African-American and Caucasian women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Overview of the summit meeting evaluating research in African-American women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Racial differences in breast carcinoma survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Hormone receptors in breast cancer: racial differences in distribution and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

A comparison of estrogen and progesterone receptors in black and white breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Racial differences in treatment and survival from early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Ethnic differences in risk and prognostic factors for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Do we need HER-2/neu testing for all patients with primary breast carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Breast carcinoma survival analysis for African American and white women in an equal-access health care system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Racial Disparity in the Dose and Dose Intensity of Breast Cancer Adjuvant Chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles in breast tumors of Caucasian women.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Disaggregating the effects of race and poverty on breast cancer outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Association of education and income with estrogen receptor status in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Participation in cancer clinical trials: race-, sex-, and age-based disparities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21463

7 January 2021

Identifiers

DOI

10.1002/CNCR.21463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16208704%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference